TCG Partner Charlie Turner Acted As Interim Business Development Leader in Key Transaction for Baxter International

Chapel Hill, NC – Initial trial results from Baxter hemophilia gene therapy program come from acquired affiliate of AskBio of Chapel Hill; TCG Partner Charlie Turner acted as interim business development leader in key transaction.

Click here to download press release